tirzepatide cardiovascular outcomes trial results july 2025

tirzepatide cardiovascular outcomes trial results july 2025 US Population Eligibility and Estimated Impact of Treatment on Obesity Prevalence and Disease Events | Cardiovascular Drugs and Therapy 60-Second Journal Club: The SUMMIT

Name: tirzepatide cardiovascular outcomes trial results july 2025 US Population Eligibility and Estimated Impact of Treatment on Obesity Prevalence and Disease Events | Cardiovascular Drugs and Therapy 60-Second Journal Club: The SUMMIT
Brand: museeartisanaletruralclion.fr
SKU: 69482981949
Price: 29.78 USD
Availability: InStock
Rating: 4.446400000000001 (5 reviews)

SKU: 69482981949

4.4

USD29.78 USD77.78

Pay in 4 interest-free payments of $7.45 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

Description

J Nucl Med Off Publ Soc Nucl Med

A new study published in The BMJ and described by NBC News analysed records from more than 600,000 people in a US Department of Veterans Affairs database

Research published in Cell Metabolism demonstrates that GIP receptor activation enhances nutrient partitioning, meaning the body becomes more efficient at directing calories toward metabolically active tissue rather than fat stores